Position in BMY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$139,094
-$6,284 QoQ
Shares Held
2,414
+0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#2,199
of 2,506 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026American Capital Advisory, LLC holds $3,468,342 across 15 Drug Manufacturers - General names. BMY ranks #6 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
6,146 | $789,761 | |
| 2 | ABBV |
AbbVie Inc.
|
3,087 | $776,812 | |
| 3 | LLY |
ELI LILLY & Co
|
519 | $622,504 | |
| 4 | JNJ |
Johnson & Johnson
|
2,226 | $565,337 | |
| 5 | AMGN |
Amgen Inc
|
921 | $333,512 | |
| 6 | BMY |
Bristol Myers Squibb Co
This page
|
2,414 | $139,094 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
985 | $124,444 | |
| 8 | PFE |
Pfizer Inc
|
2,842 | $68,435 |
All Filings in BMY
Export CSV
11 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $139,094 | 2,414 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $145,378 | 2,397 | Shares | Sole | 2026-04-29 | |
| 2025-12-31 | $127,729 | 2,368 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $107,022 | 2,373 | Shares | Sole | 2025-10-28 | |
| 2025-06-30 | $109,799 | 2,372 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $143,509 | 2,353 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $131,954 | 2,333 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $124,072 | 2,398 | Shares | Sole | 2024-10-30 | |
| 2024-06-30 | $334,648 | 8,058 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $436,985 | 8,058 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $413,455 | 8,058 | Shares | Sole | 2024-04-09 | |
| No filing history on record for this holder in this stock. | ||||||